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Background/aim: To investigate total oxidant and antioxidant status, maximal aerobic capacity, daily physical activity, pulmonary
functions, and body composition changes, as well as the associations among these parameters, in patients with mild to moderate chronic
obstructive pulmonary disease (COPD) versus healthy controls.
Materials and methods: The study included 30 male patients newly diagnosed with COPD and 30 body mass index-matched, nonsmoker
male controls. Maximal aerobic capacity, daily physical activity, total oxidant and antioxidant status, pulmonary function tests, body
composition, and anthropometric parameters were measured.
Results: Maximal aerobic capacity and total antioxidant values were lower in patients with COPD compared to the controls. The total
oxidant value, body fat percentage, and waist/hip ratio were higher in patients with COPD than in the healthy controls. There was a
moderately negative correlation between the total oxidant value and the maximal aerobic capacity, while there was a moderately positive
correlation between the total antioxidant values and maximal aerobic capacity in patients with COPD.
Conclusion: Low aerobic capacity, increased oxidative stress, and adiposity are related to impaired pulmonary functions in patients with
mild to moderate COPD and might have a role in the pathogenesis of COPD.
Key words: Chronic obstructive pulmonary disease, maximal aerobic capacity, oxidative stress, daily physical activity, body fat

1. Introduction
Chronic obstructive pulmonary disease (COPD), one
of the most common chronic diseases, is a major cause
of morbidity. Oxidative stress is a situation of imbalance
between free radicals and antioxidants in favor of the
oxidants (1). Today, habitual smoking is the most significant
threat to the world’s population (2). The development
of COPD is mainly associated with tobacco or biomass
smoke-induced oxidative stress. Smokers are exposed to
thousands of reactive chemicals and trillions of radicals
and particles with every cigarette; thus, the molecular
reactive oxygen, activity of radicals, and nitrogen species
can, over time, lead to a number of detrimental changes in
the lungs (3). Oxidative stress is thought to play a central
role in the pathogenesis of COPD.
Maximal aerobic capacity (VO2max) is considered
the gold standard for evaluating cardiorespiratory fitness
(physical functional capacity) (4). Daily physical activity is
the actual level of physical performance that one adopts in
* Correspondence: dragenc@hotmail.com
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daily living. It is not synonymous with physical functional
capacity, which can be defined as the maximal performance
potential of an individual (5). Aerobic exercise limitation
is a common and disturbing manifestation of COPD and
is often caused by multiple interrelated physiologic and
anatomic disturbances (6). Nevertheless, a hypothesis was
proposed that individuals with higher current aerobic
function will have greater antioxidant and metabolic
capacities to deal with the stresses associated with life,
including environmental stresses such as chronic cigarette
smoke exposure (3).
Patients with COPD show high prevalences of
cardiovascular diseases and metabolic syndrome (7,8).
Obesity and COPD are common and disabling chronic
health conditions. A relationship between obesity and
COPD is increasingly recognized, although the nature of
this association remains unknown (9). Uygur et al. also
found that body fat percentage and total body fat were
negatively correlated at a strong level with aerobic capacity
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in obese individuals (10). The potential interaction among
aerobic capacity, oxidative stress, daily physical activity,
pulmonary function, and body composition parameters
in mild to moderate COPD may provide more insight
into some physiopathological aspects of the disease at the
initial stage.
The aim of this study was to investigate total oxidant
and antioxidant status, VO2max, daily physical activity,
pulmonary functions, and body composition changes as
well as the associations among these parameters in patients
with mild to moderate COPD versus healthy controls.
2. Materials and methods
2.1. Study design
This study was designed as a comparative association
analysis between patients with COPD and healthy controls
regarding total oxidant and antioxidant status, maximal
aerobic capacity, daily physical activity, pulmonary
function tests, body composition, and anthropometric
parameters. Patients referred to the Department of
Pulmonary Medicine of the Afyon Kocatepe University
Faculty of Medicine were preselected for the study
following a prediagnosis of COPD. The controls were
preselected from among voluntary individuals who came
to our exercise physiology laboratory and wanted to know
their own body composition and physical fitness status.
The study protocol was approved by the local ethics
committee of clinical research. All patients and controls
participated voluntarily with written informed consent.
The patients were diagnosed with COPD by trained
pulmonary medicine specialists. Classification of disease
severity was made with Global Initiative for Chronic
Obstructive Lung Disease (GOLD) recommendations
(11). Inclusion criteria included having no risks associated
with exercise. Exclusion criteria included asthma, atopy,
major musculoskeletal problems, use of drugs such as betablockers affecting heart rate, acute infection, dehydration,
metabolic and cardiovascular diseases, and respiratory
disorders other than COPD. The study ultimately included
60 male participants: 30 current smoker patients with
COPD and 30 body mass index (BMI)-matched healthy
nonsmoker controls.
2.2. Anthropometric measurements
BMI was calculated as body weight divided by the square
of the height (kg/m2). BMI does not give any information
about the fat distribution in the body (12). The waist/hip
ratio shows central adiposity. Waist and hip circumference
measurements were taken at anatomical positions with a
7-mm-wide tape measure. The tape measure completely
surrounded the part of the body, but did not compress the
subcutaneous fat tissue (13). The waist/hip ratio was also
calculated.

2.3. Body composition
Body composition parameters were determined with the
bioelectrical impedance analysis (BIA) method (Bodystat
1500, Bodystat Ltd., UK). Some precautions were taken
before the measurements, as follows (4,14,15): the subjects
were instructed to avoid strenuous exercise for 24 h,
eating or drinking within 4 h, using diuretics within 7
days, and alcohol consumption for 48 h before the test
procedure. The basic premise of the BIA method is that
the volume of fat-free tissue in the body is proportional to
the electrical conductivity of the body (4). Impedance was
measured between the right wrist and right ankle using a
tetrapolar electrode system (16). The data were analyzed
using the manufacturer’s software, and body composition
parameters (body fat %, total body fat, and lean body
mass) were determined for each subject.
2.4. Maximal aerobic capacity
VO2max was estimated with the Astrand exercise test
protocol (17). Before the exercise test, the risk of exercise
for the subjects was assessed according to American
College of Sports Medicine criteria (18). The exercise test
was performed with appropriate equipment and physician
supervision. The subjects were instructed to avoid food
intake 2 h before the test and avoid beverages or foods
containing alcohol or caffeine (19). The Astrand test is
a valid submaximal exercise test for estimating VO2max
(20). It was performed on a computerized cycle ergometer
(Monark 839E, Monark Exercise AB, Sweden), and heart
rate was monitored with a chest belt telemetry system
(Polar, Monark Exercise AB, Sweden). VO2max was
expressed in liters per minute VO2max and in milliliters
per kilogram of body weight VO2max (21).
2.5. Daily physical activity
Daily physical activity was measured with a 3-axial
accelerometer (RT3, StayHealthy Inc., USA). The
accelerometer was attached to a belt using the integral belt
clip and worn on the patient’s right hip. The epoch interval
was set at 1 min, and the output was expressed as mean
counts per minute for each activity (22). The subjects were
monitored with the accelerometer for 12 h (0800–2000
hours) per day for 3 days. The mean value of 3 days was
calculated (kcal/12 h).
2.6. Total oxidant and antioxidant status
Venous blood samples from the antecubital vein were
collected in 5-mL vacutainer tubes in the morning at 0830–
1000 hours after overnight fasting. The blood samples were
centrifuged at 4000 rpm for 4 min to obtain plasma. The
plasma samples were collected and stored frozen at –20 °C
until analysis.
Total oxidant status was measured colorimetrically
using the TOS Kit (Rel Assay Diagnostics, Turkey). The
plasma total oxidant status levels were determined using
a novel automated measurement method developed by
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Erel (23). In this method, oxidants present in the sample
oxidize the ferrous ion–o-dianisidine complex to ferric ion.
The oxidation reaction is enhanced by glycerol molecules,
which are abundantly present in the reaction medium. The
ferric ion makes a colored complex with xylenol orange
in an acidic medium. The color intensity was measured
spectrophotometrically (Jenway 6105 UV/Vis, UK). The
assay was calibrated with hydrogen peroxide, and the
results were expressed in terms of micromolar hydrogen
peroxide equivalent per liter (µmol H2O2 Eq/L). The
precision of the assay was excellent, at less than 2%.
Total antioxidant status was measured colorimetrically
using the TAS Kit (Rel Assay Diagnostics, Turkey). The
plasma total antioxidant status levels were measured using
a novel automated colorimetric measurement method
developed by Erel (24). In this method, the hydroxyl
radical is produced by the Fenton reaction, and it reacts
with the colorless substrate o-dianisidine to produce
the dianisyl radical, which is bright yellowish-brown.
After a plasma sample is added, the oxidative reactions
initiated by the hydroxyl radicals present in the reaction
mix are suppressed by the antioxidant components of the
plasma, preventing the color change. The color intensity
was measured spectrophotometrically (Jenway 6105 UV/
Vis, UK). The results were expressed as mmol Trolox
equivalent/L for plasma. The precision of the assay was
excellent, at less than 3%.
2.7. Pulmonary function tests
Pulmonary function tests were carried out with a portable
spirometer (Spirolab, SDI Diagnostics, USA). The tests
were performed room temperature (25). Forced expiratory

volume in the first second (FEV1), forced expiratory
flow at 25% to 75% of vital capacity (FEF25–75), and peak
expiratory flow (PEF) were measured (26). Maximal
voluntary ventilation was measured using another
spirometry maneuver. Acceptability criteria were applied
to all participants (27).
2.8. Statistical analysis
The data were analyzed using SPSS 16.0 (SPSS Inc., USA).
The distribution of the group was analyzed with the
Kolmogorov–Smirnov test. Differences between groups
were determined with the Student t-test. The correlations
between the parameters were analyzed with Pearson
correlation tests. All parametric results were expressed as
mean ± standard deviation for each group. The significance
level was determined as P ≤ 0.05.
3. Results
A total of 32 patients with COPD were invited to
participate in the study. Two refused to participate because
they did not want to perform the exercise tests. The mean
level of smoking was 38.1 ± 15.3 pack years in the patients
with COPD. Disease severity of the COPD patients was
classified as follows: 17 cases were mild and 13 cases were
moderate. The mean values for age, height, body weight,
BMI, waist/hip ratio, body fat percentage, total body fat,
and lean body mass in the COPD and control groups
are shown in Table 1. The waist/hip ratio and body fat
percentage values were significantly higher in patients
with COPD compared to the controls. However, the mean
BMI and lean body mass values did not differ significantly
between the patients with COPD and the healthy controls.

Table 1. Age, anthropometric measurements, and body composition parameters in
COPD and control groups.
COPD (n = 30)

Control (n = 30)

P-value

Age (years)

54.1 ± 8.1

53.0 ± 5.9

0.606

Height (cm)

169.9 ± 6.7

172.1 ± 6.7

0.250

Body weight (kg)

79.8 ± 13.8

81.2 ± 18.1

0.762

BMI (kg/m )

27.8 ± 3.7

27.3 ± 5.1

0.700

Waist circumference (cm)

94.1 ± 8.5

89.0 ± 10.8

0.080

Hip circumference (cm)

97.4 ± 7.2

97.8 ± 9.3

0.887

Waist/hip ratio

0.97 ± 0.06

0.91 ± 0.06

0.002

Body fat (%)

27.4 ± 4.4

22.7 ± 6.7

0.004

Total body fat (kg)

22.0 ± 6.0

19.3 ± 10.1

0.269

Lean body mass (kg)

57.8 ± 9.2

61.9 ± 9.4

0.122

2

BMI = body mass index.
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Table 2 lists the mean values for maximal aerobic
capacity, daily physical activity, total oxidant and
antioxidant status parameters, and pulmonary function
tests in the COPD and control groups. Total oxidant
status was significantly higher in patients with COPD
than in the controls. The mean VO2max (L/min), VO2max
(mL kg–1 min–1), and total antioxidant status values were
significantly lower in patients with COPD compared to the

controls. The mean daily physical activity value was not
significantly different between the patients with COPD and
healthy controls. All pulmonary function tests were lower
in patients with COPD than in the controls. In addition,
daily physical activity was not significantly correlated with
all of the pulmonary function tests in patients with COPD.
Table 3 shows the correlations of maximal aerobic
capacities in patients with COPD. VO2max (mL kg–1

Table 2. Maximal aerobic capacity, daily physical activity, total oxidant and antioxidant status,
and pulmonary function tests in COPD and control groups.
COPD (n = 30)

Control (n = 30)

P-value

1.90 ± 0.42

2.44 ± 0.56

<0.001

VO2max (mL kg min )

24.4 ± 5.5

30.8 ± 8.2

0.002

Daily physical activity (kcal/12 h)

632.4 ± 221.0

637.7 ± 313.5

0.944

VO2max (L/min)
–1

–1

Total oxidant status

5.38 ± 1.86

4.24 ± 1.89

0.039

Total antioxidant status

2.01 ± 0.49

2.49 ± 0.56

0.002

FEV1 (L)

2.4 ± 0.6

3.9 ± 0.6

<0.001

FEV1 (%) predicted

75.6 ± 13.9

101.2 ± 10.2

<0.001

PEF (L)

5.7 ± 1.6

9.3 ± 1.8

<0.001

PEF (%) predicted

69.7 ± 18.4

100.8 ± 17.5

<0.001

FEF25–75 (L)

1.7 ± 0.6

3.9 ± 1.3

<0.001

FEF25–75 (%) predicted

46.7 ± 14.6

87.0 ± 27.3

<0.001

MVV (L)

94.5 ± 27.6

165.6 ± 32.4

<0.001

MVV (%) predicted

78.5 ± 18.7

119.5 ± 18.6

<0.001

VO2max = maximal aerobic capacity, FVC = forced vital capacity, FEV1 = forced expiratory
volume in first second, PEF = peak expiratory flow, FEF25–75 = forced expiratory flow at 25% to
75% of vital capacity, MVV = maximal voluntary ventilation.
Table 3. The correlations of maximal aerobic capacities in COPD group.
VO2max (L/min)

VO2max (mL kg–1 min–1)

R-value

P-value

R-value

P-value

FEV1 (L)

0.501

<0.001

0.375

0.007

PEF (L)

0.407

0.003

0.282

0.042

FEF25–75 (L)

0.415

0.003

0.279

0.046

MVV (L)

0.469

0.001

0.294

0.038

Total oxidant status

–0.383

0.006

–0.269

0.048

Total antioxidant status

0.278

0.045

0.289

0.040

BMI (kg/m )

NS

NS

–0.419

0.002

Body fat (%)

NS

NS

–0.477

0.036

Lean body mass (kg)

0.480

<0.001

NS

NS

2

NS = not significant, VO2max = maximal aerobic capacity, FEV1 = forced expiratory volume in
first second, PEF = peak expiratory flow, FEF25–75 = forced expiratory flow at 25% to 75% of vital
capacity, MVV = maximal voluntary ventilation, BMI = body mass index.
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min–1) and VO2max (L/min) were positively correlated
with all pulmonary function tests and total antioxidant
status, but were negatively correlated with total oxidant
status. In addition, VO2max (mL kg–1 min–1) was negatively
correlated with BMI and body fat percentage, but VO2max
(L/min) positively correlated with lean body mass.
Table 4 lists the correlations of oxidative stress and
adiposity parameters with pulmonary function tests in
patients with COPD. Total oxidant status was negatively
correlated with all of the pulmonary function tests, and
total antioxidant status was positively correlated with
all pulmonary function tests. Body fat percentage was
negatively correlated with most of the pulmonary function
tests, but waist/hip ratio was negatively correlated with all
of pulmonary function tests.
4. Discussion
In this study, we found that maximal aerobic capacity
is lower and oxidative stress and adiposity are higher in
patients with COPD than in controls, which is in agreement
with previous reports. However, in the current study,
oxidative stress, aerobic capacity, daily physical activity,
and body composition parameters were investigated
together in newly diagnosed COPD patients who had not
been administered any medications for COPD.
Exercise capacity in patients with COPD is usually
investigated by studies using the 6-min walk test, which
has a poor methodology for assessing VO2max. Exercise
capacity has been investigated in only a limited number
of studies with an exercise test that has a good validated
methodology. Malaguti et al. measured VO2max with a
maximal cardiopulmonary exercise test and determined
muscle mass with dual-energy X-ray absorptiometry
in patients with COPD (n = 39) and controls (n = 17)
(28). The authors found that VO2max (mL kg–1 min–1)
was lower in the patient group than in the control group,
and they found no significant relationships between
VO2max and muscle mass in patients with COPD. The

authors claimed that peripheral muscle mass did not
constitute a good predictor for VO2max in patients with
COPD. Carter et al. used the progressive cycle ergometry
exercise test in patients with COPD and controls (29).
They found a progressive reduction in functional aerobic
capacity, even with mild pulmonary dysfunction, in male
patients with COPD (29). Similar to these studies, we
found that VO2max was significantly lower in patients
with COPD compared to the controls (Table 2). VO2max
showed moderate correlations with pulmonary functions
(Table 3) even if the patients with COPD had mild to
moderate levels of pulmonary dysfunction. The low
VO2max indicates weak exercise capacity in patients with
COPD. Exercise intolerance may result from ventilatory
limitation, oxidative stress, cardiovascular impairment,
deconditioning, skeletal muscle dysfunction, chronic
hypercapnia, and hypoxia in patients with COPD (30,31).
In this study, VO2max (L/min) correlated with lean body
mass, but VO2max (mL kg–1 min–1) was not significantly
correlated with lean body mass (Table 3). Lean body mass
includes fat-free body mass such as muscle mass. There
was no clear relationship between exercise capacity and
muscle mass in patients with mild to moderate COPD.
We suggest that the relationship between weak exercise
capacity and low pulmonary functions points out the
importance of exercise treatment (as a major component of
the pulmonary rehabilitation) in patients newly diagnosed
with mild to moderate COPD.
Usually, patients with COPD have a low level and
intensity of daily physical activity (5). Donaire-Gonzalez et
al. found that patients with severe and very severe COPD
performed daily activities in fewer and shorter bouts than
those in the mild and moderate stages (32). Egan et al.
reported that a 7-week pulmonary rehabilitation program
led to increased exercise capacity, but did not significantly
change the average number of daily steps taken, time spent
in sedentary activity, and daily physical activity in COPD
patients (33). In this study, the mean daily physical activity

Table 4. The correlations of oxidative stress and adiposity parameters with pulmonary function tests in COPD group.
Total oxidant status

Total antioxidant status

Body fat (%)

Waist/hip ratio

R-value

P-value

R-value

P-value

R-value

P -value

R-value

P-value

FEV1 (L)

–0.299

0.033

0.404

0.003

–0.425

0.002

–0.494

<0.001

PEF (L)

–0.337

0.016

0.406

0.003

–0.322

0.021

–0.388

0.005

FEF25–75 (L)

–0.280

0.041

0.353

0.011

NS

NS

–0.409

0.003

MVV (L)

–0.276

0.049

0.361

0.009

–0.399

0.004

–0.399

0.004

NS = not significant, FEV1 = forced expiratory volume in first second, PEF = peak expiratory flow, FEF25–75 = forced expiratory flow at
25% to 75% of vital capacity, MVV = maximal voluntary ventilation.
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value did not differ significantly between the patients with
COPD and the healthy controls (Table 2). We think that
this result confirms the results of previous studies (32,33).
In another study, a moderate to weak relationship was
found between daily physical activity and exercise capacity
in patients with COPD (34). Daily physical activities
were the most common and naturally included slow and
nonrigorous physical activities. We concluded that, due to
the patients’ mild level of pulmonary dysfunction, daily
physical activity did not decrease and was not correlated
with pulmonary function in patients with mild to
moderate COPD.
Cristóvão et al. evaluated a biomarker of oxidative
stress (malondialdehyde, a lipid peroxidation-derived
product) and nonenzymatic antioxidants (the sulfhydryl
groups and vitamin C) in patients with COPD and
healthy controls (35). They found that the oxidative stress
marker was significantly higher and antioxidant status was
significantly lower in patients with COPD compared to
those in the healthy controls. They claimed that oxidative
stress is an important physiopathological change in COPD.
Hanta et al. measured erythrocyte superoxide dismutase
enzyme activity and plasma malonyldialdehyde levels in
162 subjects (30 healthy nonsmokers, 30 healthy smokers,
71 patients with stable COPD, and 31 patients with COPD
exacerbation) (36). They found that the healthy smokers
and stable and exacerbated patients with COPD had an
impairment in the oxidant–antioxidant balance. In another
study, erythrocyte superoxide dismutase enzyme activity
was increased in patients with COPD and in healthy
smokers compared to healthy nonsmokers (37). Altuntas
et al. studied the levels of plasma malonyldialdehyde,
erythrocyte reduced glutathione, and erythrocyte catalase
in 20 patients with COPD, 20 healthy smokers, and 20
healthy nonsmokers (38). They found that the antioxidant
capacity was lower and the oxidant capacity was higher in
patients with COPD and in the healthy smokers compared
to the nonsmoker controls. Pinho et al. also stated that
patients with COPD are characterized by increased
systemic and pulmonary oxidative stress markers
(39). Similarly, we found that total oxidant status was
significantly higher and total antioxidant status values were
significantly lower in patients with COPD compared to the
controls (Table 2). Altuntas et al. reported that increased
oxidant capacity and decreased antioxidant capacity
were not correlated with spirometric measurements of
airway obstruction in patients with COPD or in healthy
smokers (38). However, in our study, pulmonary function
tests showed moderate negative correlations with the
total oxidant value and moderate positive correlations
with the total antioxidant value (Table 4). In addition, a
moderately negative correlation between total oxidant
value and maximal aerobic capacity and a moderately

positive correlation between total antioxidant values and
maximal aerobic capacity were found (Table 3). Increased
oxidative stress, decreased antioxidant capacity, impaired
pulmonary functions, and low aerobic capacity are
interrelated parameters in patients with mild to moderate
COPD.
The increased oxidative stress in patients with COPD is
the result of exogenous oxidants (namely, cigarette smoke
and pollutants) as well as endogenous oxidant production
during inflammation (35). Aerobic capacity is a complex,
polygenetic trait closely associated with mitochondrial
function, which includes aerobic energy production and
antioxidant capacity (3). Smoking can directly damage
mitochondria, and antioxidant capacity can lead to greater
oxidative damage. In this study, although there was no
significant difference between the values for daily physical
activity in the COPD and control groups, the aerobic capacity
values were lower in the patients with COPD than in the
healthy controls. Our results include evidence supporting
the proposal that low aerobic capacity individuals with
decreased antioxidant capacity will not be protected from
the oxidant damage elicited by cigarette smoke (3).
Abdominal fat mass contributes to systemic inflammation in patients with COPD (40). Akpınar et al. studied 91
stable patients with COPD and 42 control subjects (8). The
authors found that the frequency of metabolic syndrome
was higher in the patient group than in the controls. Components of metabolic syndrome like abdominal obesity,
hyperglycemia, and hypertension were significantly more
prevalent in the patient group (8). In another study, metabolic syndrome and abdominal obesity were often found
in patients with COPD (41). Furutate et al. used computed
tomography to evaluate the subcutaneous fat area, the abdominal visceral fat area, and the extent of emphysema in
patients with COPD and controls (42). They found that
patients with COPD had excessive visceral fat, which is
retained in patients with more advanced stages of COPD
despite the absence of obesity. In the current study, the patients with COPD were overweight (Table 1) and had mild
to moderate levels of pulmonary dysfunction. In contrast,
we examined patients with mild to moderate COPD, but
we found that the waist/hip ratio (central obesity) was significantly higher in patients with COPD than in the controls (Table 1). Similar to our study, Park et al. (43) studied
patients newly diagnosed with COPD and evaluated the
relationship between COPD and metabolic syndrome in
133 patients. The authors found that the prevalence of metabolic syndrome was significantly higher in patients with
COPD compared with subjects without COPD in both
sexes. In addition, a significant association was found between COPD and abdominal obesity in patients with metabolic syndrome (43). Our results are relevant to research
into developing processes of central obesity, a component
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of metabolic syndrome in patients with COPD. The mean
BMI and lean body mass values did not differ significantly
between the COPD and control groups, whereas the value
for body fat percentage was higher in patients with COPD
than in the healthy controls (Table 1). In addition, the
waist/hip ratio and body fat percentage were negatively
correlated with almost all of the pulmonary function tests
(Table 4). Our hypothesis that body adiposity (especially
central obesity) as opposed to depleted muscle mass was
the prominent feature of body composition in newly diagnosed patients with COPD was confirmed. In addition,
these results imply that a negative energy balance did not
occur in patients with mild to moderate COPD.
In conclusion, lower maximal aerobic capacity and
higher oxidative stress, body fat percentage, and central
obesity were found in patients with mild to moderate

COPD compared to healthy controls. Low aerobic
capacity, increased oxidative stress, and adiposity are
related to impaired pulmonary functions in patients with
COPD and might have a role in the vicious circle of the
pathogenesis of COPD. Further studies are needed to
evaluate the associations of these parameters in patients
with COPD together with healthy smokers who have not
developed COPD yet.
A lack of validity studies that use the Astrand
submaximal exercise test in patients with COPD is a
limitation of this study.
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